Brief: Athenex Announces Sale Of Revenues From U.S. And European Royalty And Milestone Interests In Klisyri® (Tirbanibulin) To Sagard Healthcare Partners And Oaktree

Athenex

22/06/2022 15:41

June 22 (Reuters) - Athenex Inc  ATNX.O :
    * ATHENEX ANNOUNCES SALE OF REVENUES FROM U.S. AND EUROPEAN
ROYALTY AND MILESTONE INTERESTS IN KLISYRI® (TIRBANIBULIN) TO
SAGARD HEALTHCARE PARTNERS AND OAKTREE
    * ATHENEX INC - TOTAL TRANSACTION VALUE OF $85 MILLION; AT
LEAST
$80 MILLION TO BE USED TOWARD DEBT PAYDOWN AND TO FUND
OPERATIONS
    * ATHENEX - SALE OF REVENUES FROM U.S. AND EUROPEAN ROYALTY
IN
KLISYRI TO SAGARD HEALTHCARE PARTNERS & FUNDS MANAGED BY OAKTREE
CAPITAL MANAGEMENT

Source text for Eikon:  ID:nGNX99tjxP 
Further company coverage:  ATNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))